An mRNA vaccine produced by Moderna and Merck reduced the risk of skin cancer metastasis or death by 65%, according to clinical trial results shared at the 2023 session of the American Society of...
In a statement issued on May 24, 2023, Qilu Pharmaceutical Co, a Chinese pharmaceutical company, will export cisplatin, a chemotherapy drug, to the United States. Amidst shortages that began in early...
On June 1, 2023, the National Cancer Institute (NCI), a subset of the NIH, launched ComboMATCH, a precision medicine initiative for cancer patients. ComboMATCH — short for Combination Therapy...
On May 31, 2023, JAMA Network Open published an article detailing the impacts of perfluoroalkyl and polyfluoroalkyl substance (PFAS) exposure on birth outcomes. Researchers determined that exposure to...
On May 30, 2023, the United States Food and Drug Administration (FDA) proposed an additional Patient Medication Information (PMI) section on human prescription drug labels, amending current...
Compounded forms of semaglutide have been linked to adverse events, leading to FDA-issued warnings. As a result, the FDA recommends that patients avoid compounded semaglutide whenever the approved...
Nearly every medical device or pharmaceutical company has a medical affairs team responsible for gathering scientific data and communicating it with leaders in the pharmaceutical industry. However, a...
An open-label, randomized, noninferiority trial published in the New England Journal of Medicine revealed that ketamine and electroconvulsive therapy (ECT) were equally effective at managing...
While not a new concept, drug rationing across the United States has become an increasingly critical issue. In another tale about the dangers of high prescription drug costs, researchers published an...
Gaining popularity from celebrity endorsements and public speculation, Ozempic has become a staple weight loss drug in the United States. However, researchers speculate that the medication could...
Federal Trade Commission (FTC) officials are taking Amgen and Horizon to court this September to block a prospective pharmaceutical acquisition of the two companies. The FTC announced that it planned...
On May 22, 2023, the FDA approved Opvee, a nalmefene hydrochloride nasal spray that can reverse an opioid overdose in patients 12 and older. This approval adds a harm-reduction tool to existing tools,...
On May 18, 2023, the United States Food and Drug Administration (FDA) approved RINVOQ, manufactured by Abbvie, as a once-daily treatment for adults with moderate or severely active Crohn’s...
On May 19, 2023, the CDC released an update on the Pseudomonas aeruginosa outbreak linked to artificial tears from Global Pharma Healthcare. The report identifies a fourth death linked to the series of...
Adding to the significant progression of mRNA vaccines in cancer care, Memorial Sloan Kettering Cancer Center (MSKCC) researchers have announced promising results from a phase 1 clinical trial using...
The NIH’s National Institute of Allergy and Infectious Disease (NIAID) Vaccine Research Center (VCR) researchers have begun phase 1 clinical trials on a universal mRNA influenza vaccine. The...
On May 11, 2023, the United States FDA Pulmonary–Allergy Drug Advisory Committee (PADAC) favored the approval of Neffy, the first intranasal epinephrine spray for allergic reactions. The panel...
After months of deliberation and review, the FDA has finally expanded its blood donor eligibility by adjusting its donation guidelines. Joining other developed nations, including the United Kingdom and...
In April, the United States Food and Drug Administration (USFDA) announced a shortage of injectable penicillin, penicillin G benzathine, adding to the never-ending list of medications with supply chain...
Echoing the voices of multiple major healthcare organizations and public health leaders, a joint FDA advisory panel favored making a birth control pill available over the counter (OTC). FDA leaders...
